510(k) Report

510(k) · Cleared

Cleared

Genesis Ecp

K081359510(k) SpecialCleared May 29, 200814-day reviewClass II21 CFR 870.5225

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Scottcare Corporation · DRN Device, Counter-Pulsating, External

Cleared on May 29, 2008 as substantially equivalent to K023016 (Nicore Equipment & Leasing, Inc., 2002) after a 14-day review. Its family tree reaches back 1 generation to 2002.

Decided
May 29, 2008
Review
14 days
Class
Class II
Product code
DRN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K023016 (2002). No later device cites it as a predicate yet.

K023016 · Nicore Model NCP-1 External Counterpulsation Device · Nicore Equipment & Leasing, Inc. · 2002200020022004200620082010
  1. Root · 1 generation backK023016 Nicore Model NCP-1 External Counterpulsation DeviceNicore Equipment & Leasing, Inc. · 2002
  2. This deviceK081359 Genesis EcpScottcare Corporation · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K023016Nicore Model NCP-1 External Counterpulsation DeviceNicore Equipment & Leasing, Inc.2002—
0 (this device)K081359Genesis EcpScottcare Corporation2008—
FIG. 1 — Lineage of K081359, 2002–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DRN device

  1. #1 K250756 Pression Wave PRO External Counter-Pulsation…score 10.9 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K023016Nicore Model NCP-1 External Counterpulsation Device
Summary page 1
…counter-pulsating device, Product Code: DRN Leqally Marketed Predicate Device(s): Model NCP-1 Counter Pulsation Device K023016, December 12, 2002 2- 0001…
Nicore Equipment & Leasing, Inc.2002—

Also cleared against K023016: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate K023016.

How does its category compare?

All DRN devices

DRN Device, Counter-Pulsating, External: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · DRN

1in 2025

2008: 12009: 12013: 12015: 12018: 12019: 12020: 22025: 1
2007high 2 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DRN

Too few DRN 510(k)s in any year since 2007 to give a median.

Recalls per year · DRN

1in 2009

2009: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DRN

1in 2024

2007: 22016: 12024: 1
2007high 2 (2007) · low 0 (2008)2025

MAUDE reports naming product code DRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20081—00
20091—10
20100—00
20110—00
20120—00
20131—00
20140—00
20151—00
20160—01
20170—00
20181—00
20191—00
20202—00
20210—00
20220—00
20230—00
20240—01
20251—00
20260—0—

What is it indicated for?

The intended use of the ScottCare Genesis ECP device is to provide external counterpulsation (ECP) therapy, and is indicated for use in the treatment of stable or unstable angina pectoris, congestive heart failure, cardiogenic shock, and acute myocardial infarction.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K081359: Genesis Ecp.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K081359

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026